New research found hospital visits from Ozempic and Wegovy are rare, but can be serious. Experts explain the finding and ...

Novo Nordisk (NYSE: NVO) has seen revenue soar in recent years thanks to two drugs that have helped people around the world ...

Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...

A Kentucky doctor faces up to three years in prison after admitting he sold patients a non-approved weight-loss drug. Matthew ...

ASHLAND A local family physician and former Ashland School Board member pleaded guilty on Tuesday to federal charges related to the unlawful distribution of weight loss drugs on the heels of his ...

An Ashland physician and owner of Lewis Family Care, Matthew Lewis, 44, has pleaded guilty at U.S. District Court in Ashland ...

Novo Nordisk, the maker of Ozempic and Wegovy, has also jumped into the legal fight —this time by intervening in the OFA’s lawsuit against the FDA. The company supports the agency’s move to restrict ...

Weight loss platform Noom launched a full-page print ad in The Wall Street Journal this week, calling on policymakers to ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Felix. In this article, we will summarize the bulls’ ...

Ozempic, initially for type 2 diabetes, has gained popularity for rapid weight loss, leading to a newly reported side effect ...

When it comes to weight loss, there are numerous strategies and approaches that claim to deliver results. However, not all of them are backed by science. In order to achieve long-term weight loss ...